Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.

Johnston JA, Kawamura M, Kirken RA, Chen YQ, Blake TB, Shibuya K, Ortaldo JR, McVicar DW, O'Shea JJ.

Nature. 1994 Jul 14;370(6485):151-3.

PMID:
8022485
3.
4.

Signal transduction of interleukin 2 in human natural killer cells: involvement of the p56lck tyrosine kinase.

Vitte-Mony I, Delespine-Carmagnat M, Bertoglio JH.

Mol Immunol. 1994 Jun;31(8):623-32.

PMID:
7910947
5.
7.

Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.

Hallek M, Neumann C, Schäffer M, Danhauser-Riedl S, von Bubnoff N, de Vos G, Druker BJ, Yasukawa K, Griffin JD, Emmerich B.

Exp Hematol. 1997 Dec;25(13):1367-77.

PMID:
9406996
8.
9.

Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.

Behbod F, Erwin-Cohen RA, Wang ME, Trawick BW, Qu X, Verani R, Kahan BD, Stepkowski SM, Kirken RA.

J Immunol. 2001 Mar 15;166(6):3724-32.

10.

Transmembrane signaling by the interleukin-2 receptor: progress and conundrums.

Mills GB, Schmandt R, Gibson S, Leung B, Hill M, May C, Shi YF, Branch DR, Radvanyi L, Truitt KE, et al.

Semin Immunol. 1993 Oct;5(5):345-64. Review.

PMID:
8260651
11.

Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.

Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, Wasik MA.

Leuk Res. 1999 Apr;23(4):373-84.

PMID:
10229324
12.

Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.

Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN.

Nature. 1994 Jul 14;370(6485):153-7.

PMID:
8022486
13.

Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7.

Musso T, Johnston JA, Linnekin D, Varesio L, Rowe TK, O'Shea JJ, McVicar DW.

J Exp Med. 1995 Apr 1;181(4):1425-31.

14.

Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy.

Kryworuchko M, Pasquier V, Keller H, David D, Goujard C, Gilquin J, Viard JP, Joussemet M, Delfraissy JF, Thèze J.

AIDS. 2004 Feb 20;18(3):421-6.

PMID:
15090793
15.

Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12.

Bacon CM, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, Johnston JA.

J Exp Med. 1995 Jan 1;181(1):399-404.

16.

Hypertonic saline activates protein tyrosine kinases and mitogen-activated protein kinase p38 in T-cells.

Junger WG, Hoyt DB, Hamreus M, Liu FC, Herdon-Remelius C, Junger W, Altman A.

J Trauma. 1997 Mar;42(3):437-43; discussion 443-5.

PMID:
9095111
17.

Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15.

Adunyah SE, Wheeler BJ, Cooper RS.

Biochem Biophys Res Commun. 1997 Mar 27;232(3):754-8.

PMID:
9126349
18.

Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.

Adachi M, Ishino M, Torigoe T, Minami Y, Matozaki T, Miyazaki T, Taniguchi T, Hinoda Y, Imai K.

Oncogene. 1997 Apr 3;14(13):1629-33.

19.

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L.

Biochem J. 1998 Sep 1;334 ( Pt 2):297-314. Review.

Items per page

Supplemental Content

Write to the Help Desk